人类AKT2组成性激活导致低血糖而不伴脂肪肝或代谢性血脂异常
两例携带AKT2 p.Glu17Lys突变的17岁男性,经双能X线吸收法体成分分析、过夜血糖胰岛素脂肪酸谱、口服葡萄糖耐量试验及磁共振波谱评估肝脏甘油三酯,并量化肝脏从头脂肪生成。两例脂肪占比均37%,一例过夜空腹2小时后出现低血糖伴血浆脂肪酸和酮体抑制,另一例维持血糖正常伴游离脂肪酸升高;两例口服葡萄糖后血糖波动正常但胰岛素浓度低,血浆甘油三酯、肝脏甘油三酯及空腹肝脏从头脂肪生成均正常。
要点
- AKT2 p.Glu17Lys突变赋予激酶低水平组成性活性,导致低血糖伴脂肪组织脂肪酸释放受抑。
- 两例患者血浆甘油三酯、肝脏甘油三酯含量及空腹肝脏从头脂肪生成均正常,未出现脂肪肝或高甘油三酯血症。
- 一例过夜空腹2小时后出现低血糖伴脂肪酸和酮体抑制,另一例维持血糖正常伴游离脂肪酸升高,低血糖可能自发缓解。
核心结论
- AKT2 p.Glu17Lys突变赋予该激酶低水平组成性活性,产生低血糖并抑制脂肪组织脂肪酸释放,但不导致脂肪肝、高甘油三酯血症或肝脏从头脂肪生成升高;低血糖可能自发缓解。
研究设计与样本
- 对两例既往报道的17岁男性AKT2 p.Glu17Lys突变患者进行代谢与细胞学特征分析。
- 采用双能X线吸收法进行体成分分析,过夜监测血浆葡萄糖、胰岛素和脂肪酸,行口服葡萄糖耐量试验,并用磁共振波谱测定肝脏甘油三酯含量。
- 通过氘掺入棕榈酸量化肝脏从头脂肪生成,并在体外研究真皮成纤维细胞信号传导。
主要发现
- 两例患者脂肪占比均为37%。
- 一例过夜空腹2小时后出现低血糖,伴血浆脂肪酸和酮体同时受抑;另一例维持血糖正常,伴游离脂肪酸升高。
- 两例口服葡萄糖后血糖波动均正常,但血浆胰岛素浓度低。
- 两例血浆甘油三酯浓度、肝脏甘油三酯含量及空腹肝脏从头脂肪生成均正常。
- 一例患者真皮成纤维细胞显示AKT及部分下游底物低水平组成性磷酸化,但细胞增殖速率未增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The activating p.Glu17Lys mutation in AKT2, a kinase mediating many of insulin's metabolic actions, causes hypoinsulinemic hypoglycemia and left-sided hemihypertrophy. The wider metabolic profile and longer-term natural history of the condition has not yet been reported. OBJECTIVE: To characterize the metabolic and cellular consequences of the AKT2 p.Glu17Lys mutation in two previously reported males at the age of 17 years. DESIGN AND INTERVENTION: Body composition analysis using dual-energy X-ray absorptiometry, overnight profiling of plasma glucose, insulin, and fatty acids, oral glucose tolerance testing, and magnetic resonance spectroscopy to determine hepatic triglyceride content was undertaken. Hepatic de novo lipogenesis was quantified using deuterium incorporation into palmitate. Signaling in dermal fibroblasts was studied ex vivo. RESULTS: Both patients had 37% adiposity. One developed hypoglycemia after 2 hours of overnight fasting with concomitant suppression of plasma fatty acids and ketones, whereas the other maintained euglycemia with an increase in free fatty acids. Blood glucose excursions after oral glucose were normal in both patients, albeit with low plasma insulin concentrations. In both patients, plasma triglyceride concentration, hepatic triglyceride content, and fasting hepatic de novo lipogenesis were normal. Dermal fibroblasts of one proband showed low-level constitutive phosphorylation of AKT and some downstream substrates, but no increased cell proliferation rate. CONCLUSIONS: The p.Glu17Lys mutation of AKT2 confers low-level constitutive activity upon the kinase and produces hypoglycemia with suppressed fatty acid release from adipose tissue, but not fatty liver, hypertriglyceridemia, or elevated hepatic de novo lipogenesis. Hypoglycemia may spontaneously remit.
引用
- Minic M, Rocha N, Harris J, et al. Constitutive Activation of AKT2 in Humans Leads to Hypoglycemia Without Fatty Liver or Metabolic Dyslipidemia. J Clin Endocrinol Metab. 2017. PMID: 28541532. doi:10.1210/jc.2017-00768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。